Organizer: National Institute of Allergy and Infectious Diseases
About the Workshop
- When: JULY 27-28, 2022
- Virtual and Free to Attend
Keynote | Targeted protein degradation as a therapeutic modality: Current applications in oncology and beyond Dr. Danette Daniels, VP, Protein Degrader Platform (Foghorn Therapeutics)
SESSION TOPICS
Session I: Targeting Viruses using TPD
Keynote TPD as an Antiviral Strategy, Priscilla Yang (Stanford University)
Speakers | Ivan Dikic (Goethe University), Suresh Kumar (Progenra), Scott Mills (C4 Therapeutics, Inc.), Robert C. Reynolds (University of Alabama at Birmingham) & Matthew Disney (Scripps Research Institute)
Session II: Targeting Bacteria and Fungi Using “Degraders”, LYTAC, AUTAC and other Degradation Mechanisms
Keynote | TPD: from a serendipitous discovery to a broad antibacterial approach, Thomas Dick (Seton Hall University)
Speakers | Tim Clausen (Res. Inst. Of Molecular Pathology, Austria), Chaoyang Xue (Rutgers University), Maria Górna (University of Warsaw), Michael Shiloh (University of Texas, Southwestern) & Steven Banik (Stanford University)
Breakout Sessions
- Targeting Viruses
- Targeting Bacteria and Fungi
- LYTAC, AUTAC and Other Degradation Mechanisms
Register Here
The views expressed in written conference materials or publications and by speakers and moderators at HHS-sponsored conferences do not necessarily reflect the official policies
